A CFTR gene mutation found in 90 percent of US cystic fibrosis patients was only present in a third of Puerto Rican and 10 percent of Dominican patients.
With genome sequencing, investigators tracked down a sole stool donor carrying the same multi-drug resistant form of Escherichia coli found in two FMT recipients with bacteremia.
The company also said that it has acquired Beijing-based food safety testing firm Meizheng Group. The deal is expected to expand PerkinElmer's food safety capabilities.
The company reported increase US and international revenues and test volumes, driven by increased adoption and expanding public and private payor coverage.
The lowered guidance is due to continued expected weakness in China, exacerbated by the company's decision to halt the development of new next-generation sequencing instruments.
The firm saw a 36 percent increase in influenza product sales compared to the third quarter last year.
Nippon Genetics, headquartered in Duren, Germany, offers a range of products for cell and molecular biology research.
Although the study was small, the investigators believe it provides proof of principle for the usefulness of cell-free DNA to prognose and monitor glioblastomas.
Veritas' offerings include the myGenome Standard whole-genome sequencing service, as well as the myGenome Premium and myGenome Diagnostic services.
Akadeum is currently developing a tool that involves microbubbles to deplete background molecules from circulating tumor cells in liquid biopsies.
The educational grant will support UpToDate's development of technology to help medical professionals advise their patients on health implications of genetic tests.
Under the non-exclusive agreement, the firms will make Twist's portfolio of NGS target enrichment products available for MGI's sequencing platforms.
The company plans to use the financing to fund part of its 21.4 billion pending acquisition of GE Biopharma.
UK-based Mologic said that it expects to expand its presence in Cambridge, Massachusetts through a joint development center within Sherlock’s lab space.
CMS has attempted to address stakeholders' concerns about its coverage criteria for germline NGS testing in a new proposed national policy.
The firm will use the net proceeds for research and development, marketing, and general corporate purposes to help commercialize its LX Analyzer technology.
The firm reported that test volumes for its Cologuard colorectal cancer screening test rose 89 percent year over year.
After the merger closes, the combined company will be split into four units focused on Cologuard, Oncotype Dx, international business, and pipeline efforts.
The partners will integrate Genialis' gene expression analysis software with Thermo Fisher's Invitrogen Collibri Stranded RNA Library Prep kits.
The scientists aim to use single-cell analysis to investigate the role of variation in a gene called ID3 in vascular smooth muscle cells.
Clinical services revenues rose 56 percent to $92.6 million while pharma services grew 26 percent to $12.1 million.
Waters posted revenues of $577.3 million, short of the average Wall Street estimate of $588.9 million, as soft US pharma sales negatively impacted businesses.
The company will use its InVisionFirst-Lung test to study resistance mutations in patients treated with Pfizer's ALK inhibitor lorlatinib.
Cambridge, UK-based Sense Biodetection will use the funding to develop a portfolio of instrument-free, point-of-care molecular diagnostic tests.
The company said it anticipates that more than 60 million Medicare beneficiaries will be covered for the ExoDx Prostate IntelliScore (EPI) test on Dec. 1.
The General Data Protection Regulation has slowed some data sharing with non-European researchers as they find ways to comply with the law, ScienceInsider reports.
A bioethicist from Abertay University uses a utilitarian approach to justify genetically modifying the human germline, the BBC reports.
The US has upgraded its network of public health labs to provide whole-genome sequencing to track antibiotic-resistant bacteria, Quartz reports.
In Science this week: approach to visualize 3D genome structure in single cells, RNA interference knockdown screens to examine genetic origins of beetle horns and insect wings, and more.